Pharmaceutical Science Update

Trump Administration Ethics Board to Review Fetal Tissue Studies (2)

China Expands Drug-Buying Program to Cut Costs for Patients

NIH Introduces Ethics Grants as Scientists Push Research Envelope

Merck, Otsuka Make R&D Pact for Buzzed-About Cancer Target

Peter Thiel-Backed Psilocybin Startup Edges Toward FDA Approval

Clinical DNA Lab Tests Fail to Analyze 25% of Genes, Study Finds

FDA Drug Approvals Require Less Rigorous Evidence, Study Finds

AstraZeneca Abandons Fish Oil Pill for Bad Cholesterol

First Treatment for Some Gastrointestinal Tumors Approved

‘Pharmacy Tourism’ Bill in Washington Aims for State Savings

GE’s Supreme Court Appeal Plan Tests Patent Challenge Tactics

Missing Study Findings Leave Public in Dark and $4 Billion Short

Capsule: HIV Drug Spat Heats Up and IT Wonks Talk Health Gaps

Rare Disease Drugs Turning Huge Profits Catch Congress’ Eye

Gates Research Institute to Develop Glaxo’s Promising TB Vaccine

J&J Says Developing Preventive Coronavirus Vaccine

First Peanut Allergy Drug Wins Approval From U.S. Regulators

FDA Hold on Vanda’s Long-Term Human Digestive Drug Testing OK’d

Coronavirus Outbreak Tests U.S., China’s Frayed Scientific Ties

HHS Would See $9.4 Billion Decrease Under Trump’s Budget Request

Lawmakers Ready to Unveil Bipartisan Diagnostic Test Bill

INSIGHT: How Biotech, Pharma Team Up to Promote Their Products

Esperion Directors Escape Investor Row Over Cholesterol Drug

Sanofi Brings SARS Experience to Hunt for Coronavirus Vaccine

In Fighting Outbreaks, Big Pharma Struggles to Get Out Front

House Panel Investigates Racial Profiling of Chinese Scientists

Esperion Wins FDA Approval for First Heart Medicine, Nexletol

Rare Disease Applicants Can Ditch CDs as FDA Builds Web Portal

HHS Relaxed Clinical Trial Disclosure Rule Invalid

Expired Software at NIH Put Patient Data at Risk, Watchdog Says

FDA on Watch for Drug Shortages After India Curbs Exports

Carcinogen Found by Pharmacy in Popular U.S. Diabetes Drug

Doctor Gets Warning Over Drug Study Halted by FDA

Outbreak Spurs NIH to Move Reviews of Research Grants Online

Fake Coronavirus Treatments Bring Warnings From Federal Agencies

All-or-Nothing Bet on New Bristol Myers Drugs Faces First Test

Sanofi and Regeneron Begin Initial Covid-19 Treatment Trials

Waiving Coronavirus Research Liability Driven by Lost HIV Work

Virus Delays Stir Deadline Concerns in Generic Drug Patent Cases

Censured Indian Plant Gets USFDA Nod to Supply Trump-Touted Drug

INSIGHT: Coronavirus Puts DOJ on Heightened Alert for Potential Fraud

Government May Have Ownership or Rights to Coronavirus Vaccines

How Top Scientists Are Racing to Beat the Coronavirus

Coronavirus Forces Cancer Trial Changes Patients Long Sought

Coronavirus Vaccine in 18 Months? Experts Urge Reality Check

FDA Commissioner Says China Not Creating Drug Shortages in U.S.

A Fast-Moving Virus Pits Treating Patients Against Finding a Cure

Virus Spurs Global Free-for-All Over $597 Billion Medical Trade

Troubled Overseas Drugmakers Get Free Pass in Coronavirus Crisis

AstraZeneca, Merck Drug Approved for Painful Childhood Ailment

Sanofi, Glaxo Join Forces to Develop Coronavirus Vaccine

FDA Clears Treatment for Type of Advanced Breast Cancer

First Look at Gilead Drug Virus Response to Open Data Floodgates

INSIGHT: Covid-19 Spotlights M&A International Security Concerns

No FDA Review for Most Antibody Tests Draws Rebuke from Lawmaker

Chinese Alzheimer’s Drug Gets U.S. Approval for Stateside Trial

Pandemic Hobbles Drugmakers in Recruiting for New Studies

Roche Covid-19 Antibody Test Gets Emergency FDA Approval

INSIGHT: FDA Exclusivities Add Incentives to Covid-19 Drug Race

Generic Drug Decisions Stall as Virus Disrupts Patent Lawsuits

Novavax Jumps on $388 Million Funding From Vaccine Coalition

Hopkins Helps Build Army of Virus Tracers With Online Course

Virus Collaborations Could Create Messy Patent Questions

ANALYSIS: Fractured FTC OKs AbbVie-Allergan, With Remedies

Boston Scientific Microstimulator Patent Affirmed Invalid

Glaxo HIV Study Shows Injection More Effective Than Daily Pills

Stockpile Plan Wants Makers, Sellers to Store Virus Supplies

In Reopened States, Numbers Are Everywhere. Clarity Is Absent

Health-Care Deals Drop in April, but Some Doctors Eyeing Mergers

U.K. Clears Gilead Drug for Covid-19 in Early-Access Program

Sanofi Adds Firepower in Exiting $13 Billion Regeneron Stake

Cancer Summit Presses Toward Treatments in Covid’s Shadow

Google Helps Place Ads on Sites Amplifying Covid Conspiracies

Emergent Gets $628 Million of Warp Speed Work on Covid Vaccines

Gilead Falls as Drug Has Only Small Benefit in Large Trial

Palantir Given Access to U.K. Health Data on NHS Patients

Genetron Covid-19 Test Receives FDA Emergency-Use Authorization

AstraZeneca Eyes Gilead in Big Pharma’s Move Beyond Covid

M&A Shows Signs of Covid Comeback with Hopes of Record Drug Deal

Supreme Court Passes on Eli Lilly Patent Infringement Win

Singapore Rules Out Using Apple, Google Contact-Tracing System

AstraZeneca Reaches Vaccine Supply Deal With Four EU Nations

Virus Surge Jolts Prospects for World Economy’s Nascent Recovery

Gilead to Test Inhaled Form of Anti-Covid Drug to Widen Its Use

Virus Surge Threatens Developing Nations Exiting Lockdown

INSIGHT: Telehealth Gets Boost in Response to Covid-19 Outbreak

Thailand Says It’s on Track for Covid-19 Vaccine Human Trials

Brazil Reaches Deal to Produce Oxford Covid-19 Vaccine

Gilead Says Remdesivir to Cost $2,340 for Five-Day Treatment

EU Cites ‘Constructive’ Talks With Gilead Over Virus Drug

Amgen Ruling Could Prevent Slowdowns in Biosimilar Market Entry

Post Vaccine, NIH Wants $9 Billion to Study Lasting Covid Impact

More Self-Testing for HIV Maintains Patient Care During Virus

Hong Kong’s New Virus Measures Include $645 Fine for No Mask

INSIGHT: PFAS, Covid-19, and Immune Response—Connecting the Dots

Dozens of U.S. Cities Declare Racism a Public Health Crisis

INSIGHT: Employers Have Options to Deal With Immigration, Trump’s Visa Suspension

Russian Elite Started Self-Testing Covid-19 Vaccine in April

Oxford-AstraZeneca Vaccine Shows Promise in Early Human Testing

Stem Cell Companies Get Extra Grace Period for FDA Review

IMF Grants $4.3 Billion to South Africa in Biggest Virus Loan

Low-Value Virus Research Clogging Federal Database, Study Says

Moderna Launches First Large-Scale U.S. Virus Vaccine Trial

Fauci Says Face Shields Good Idea for Teachers Back in Schools

Bid to Block LGBT Health Bias Rule Draws Questions From Judge

UPS Readies Freezer Farms to Ship Virus Vaccine—If We Get One

Trump Administration Argues for Tariffs on Janssen’s HIV Drug

Covid Vaccine for Most Americans Will Take Until Well Into 2021

States Hit Supply Limitations as They Plan to Expand Virus Tests

Lexicon Beats Investor Suit Over Statements About Diabetes Drug

Malaysia Finds More Infectious Virus Strain Seen in Europe

Covid-19 Saliva Test Partly Funded by NBA Gets FDA Authorization

Indonesia Signs Agreement With Sinovac for Covid-19 Vaccine

Takeda to Sell Consumer Unit to Blackstone for $2.3 Billion

Hong Kong Confirms First Coronavirus Re-Infection in IT Worker

Trudeau Unveils Covid-19 Vaccine Deals with Novavax, J&J

Covid-19 Antibody Race Is On as Glaxo and Vir Start Key Study

AstraZeneca Starts U.S. Final-Stage Trial of Covid-19 Vaccine

U.S. Prematurely Cancels Ventilator Contracts with Three Makers

Covid-19 May Cause Prolonged Gut Infection, Scientists Say

Drugmakers Pledge to Avoid Safety Shortcuts on Covid Vaccine

AstraZeneca Setback Delivers Reality Check on Vaccine Risks

AstraZeneca Trial on Hold Pending U.S. Scrutiny, Reuters Reports

Drugmaker Jumps 1,900% as Korea Retail Traders Bet on Covid Cure

World Governments Blasted for Lack of Pandemic Preparation

Former FDA Head Calls Azar’s Rule-Making Move a ‘Distraction’

Illumina to Buy Gates, Bezos-Backed Grail in $8 Billion Deal

Global Covid Vaccine Plan Moves Ahead, Without China for Now

Generic Drug Pricing Bill Signed by California Governor

Warning Signs Are Flashing Ahead of Covid’s Second U.S. Winter

Inovio Swoons as Covid Vaccine Trial Slowed on FDA Queries

FDA Says It Told Vaccine Makers of Principles for Emergency Use

EU Regulator Starts Review of Pfizer-BioNTech Covid Vaccine

Broader WHO Power to Probe Outbreaks Gains Countries’ Support

Genome Editing Breakthrough Awarded Chemistry Nobel Prize

FDA Stricter With Antibody Remedy Than Earlier Trump-Touted Drug

AstraZeneca’s Covid Antibody Drug Heads Into Advanced Trials

China Looking at Giving Students Vaccines Still Being Tested

CVS Adds 15,000 Workers Readying to Administer Covid Vaccines

Plans for Permanent Covid-19 Test Authorization in Works: FDA

India Will Tap Skill in Conducting Elections to Deliver Vaccine

Antibody Defense Against Covid Wanes Over Time, Study Suggests

Challenge to FDA Policy Shift on Homeopathic Drugs Stays Alive

Astra-Oxford Vaccine Stays Near Front of Line Despite U.S. Delay

Challenge to FDA Policy Shift on Homeopathic Drugs Stays Alive

Xinjiang Covid Outbreak Is China’s Biggest Since Summer

Covid Spreading Faster Than U.K. Scientists’ Worst-Case Scenario

Biden Announces 12-Member Task Force for Coronavirus Response

Viiv’s Two-Month HIV Prevention Drug Works Better than Truvada

Pfizer Soars as Vaccine Prevents 90% of Covid Cases in Study

Elon Musk’s Rapid-Test Tweets Raise More Questions Than Answers

Moderna’s Covid Vaccine Found 94.5% Effective in Early Analysis

The Case for Paying People to Get a Covid-19 Vaccine

Regeneron Gets Emergency U.S. Clearance for Covid-19 Therapy

Hospitals Lose Money, Volume as Covid Fears Keep Patients Away

Merck Buys OncoImmune for $425 Million to Gain Covid Drug

Covid Hospitalizations Hit Record as Holiday Obscures Case Data

The Toxic Substances Control Act Under Biden: Impact on Tribal, Fenceline Populations

States Fear Shortfall of Supplies for Vaccine Rollout, GAO Says

Palantir Wins FDA Contract to Power Drug Review, Inspections

Sinovac Sells $500 Million Stake as Vaccine Nears Finish Line

Pfizer, Serum Seeking Covid Vaccine Approval in India, Says PTI

First Covid Vaccines’ Triumph Raises Hope for Cancer Fight

Covid-19 Vaccine OK During Pregnancy With Doctor Consultation

Moderna Vaccine Found Safe, Effective Before Key FDA Review

U.S. Ban on U.K. Flights Isn’t Needed, Virus Team Member Says

Vaccines Don’t Mean We’ll See the Last of Covid, Experts Warn

Why the U.K.’s Mutated Coronavirus Is Fanning Worries: QuickTake